Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: Results of the nationwide HEPNET. Greece cohort study
Journal article published in 2011 by
George V. Papatheodoridis 
,
Spilios Manolakopoulos,
Giota Touloumi,
Georgia Vourli,
Maria Raptopoulou-Gigi,
Irini Vafiadis-Zoumbouli,
Themistoklis Vasiliadis,
Kostas Mimidis,
Charalambos Gogos,
Ioannis Ketikoglou,
Emanuel K. Manesis
,
Spilios Manolakopoulos,
Giota Touloumi,
Georgia Vourli,
Maria Raptopoulou-Gigi,
Irini Vafiadis-Zoumbouli,
Themistoklis Vasiliadis,
Kostas Mimidis,
Charalambos Gogos,
Ioannis Ketikoglou,
Emanuel K. Manesis
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 